Personalized Medical Devices Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

The Personalized Medical Devices Market: By Therapeutic Area (Neurology, Oncology, Cardiology, Psychiatry, Antiviral, Others) By Application (Companion Diagnostics, Biomarker identification, Health Informatics, Clinical Research), By End User(Hospitals, Molecular Diagnostic Laboratories and Testing facilities, Homecare settings, Others), By Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global Personalized Medical Devices Market size was valued at USD 494.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.3% from 2022 to 2028. Personalized Medical Devices (PM) can possibly tailor made devices with the best reaction and most noteworthy security edge to guarantee better patient care. By empowering every patient to get prior judgments, chance appraisals, and ideal medications, Personalized Medical Devices Market holds guarantee for enhancing medicinal services while additionally bringing down expenses. Medical devices companies are encountering aggressive and taken a toll weight from various sides. On one hand, rivalry emerging from developing markets requests high-volume, straightforward gadgets with bring down costs, applying weight on costs all around. Then again, organizations confront aggressive weight from new wellsprings of medicinal gadget development like added substance fabricating, which empowers unique produce of patient-particular careful instruments and implants. Some of the examples for personalized medical devices Tinnitus masker is customized by the producer to understanding tinnitus.The tinnitus treatment custom-tailors the sound signs to suit the individual patient’s listening ability necessities Pedicle screw spinal frameworks – Spinal frameworks comprising of a bar/screw/snare/connector unit are amassed by a specialist to oblige a patient’s interesting life systems/physiology utilizing MRI/CT imaging. Programming based quantitative EEG investigation intended to anticipate a person’s reaction to different psychotropic medications. The gadget gives the likelihood of reaction to different solutions to direct clinician in basic leadership. The Zenith Fenestrated AAA Endovascular Graft is demonstrated for the endovascular treatment of patients with stomach aortic or aortoiliac aneurysms having morphology reasonable for endovascular repair. The fenestrated gadget takes into account treatment of patients with shorter proximal neck lengths (i.e., length of solid aorta between the renal corridors and the aneurysm) when contrasted with the individuals who can be dealt with utilizing other endovascular joins. Every gadget is customized to the patient’s individual aortic life structures with openings in the join material set suitably to keep up blood stream to branch vessels of the aorta. The Artificial Pancreas Device System is a gadget under clinical examination that naturally screens understanding glucose levels and conveys persistent customized insulin measurements in individuals with diabetes.

Personalized Medical Devices Market

MARKET SUMMARY
-
6.3%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 6.3%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Personalized Medical Devices Market

  • Global Personalized Medical Devices Market report gives comprehensive outlook on Personalized Medical Devices across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global market gives historical, current, and future market sizes (US$ Bn) on the basis of therapeutic area, application, end user and region.
  • This report studies global Personalized Medical Devices Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • Key stakeholders of the global market report include suppliers, manufacturers, marketers, and policy makers engaged in global Personalized Medical Devices Market.
Market Key Players
  • Becton, Dickinson and Company (USA)
  • Abbott Laboratories, Inc. (USA)
  • bioMerieux, Inc. (France)
  • Biomerica, Inc.(USA)
  • Olympus Corporation (Japan)
  • Qiagen N.V. (Geramany)
  • Siemens AG (Germany)
  • Thermo Fischer Scientific, Inc. (USA).
Market Dynamics

Personalized Medical Devices Market

Personalized Medical Devices market is relied upon to witness fast development because of expanding illness occurrence and profound focal point of launching new products for tumor patients where viability has been turned out to be higher when contrasted with different treatments. Quick outcomes and tweaked impacts, bring down likelihood of prescription defects and unfriendly medication responses are a portion of alternate factors that could make reasonable footing in both R&D and income potential for these solutions. Late advancements in the pharmacogenomics are relied upon to make appropriate condition for developing devices, which are particular to one patient or gathering. Advancement of hereditary databases could give extra lift to the market. Up and coming remedial application openings in fields, for example, cardio-renal, neurology, antiviral, pneumonic, psychiatry among others could make R&D footing over all locales. High advancement costs, problematic improvement structure and between understanding changeability of impacts are a portion of the limitations that could hamper income development of the Personalized Medical Devices market.


North-America Got Significant Share

Personalized Medical Devices Market

Geographically Personalized Medical Devices Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America overwhelms the Personalized Medical Devices market, followed by Europe. The market in the Asia Pacific and Latin America is developing. Accessibility of extensive patient pool, development of the social insurance industry, and ascend in government interests in change of medicinal services are foreseen to push the market in these areas. The Personalized Medical Devices market in nations like Brazil, China, and India is anticipated to extend at a generous development rate amid the forecast period, because of ascending in awareness among individuals about the use of the customized treatment to treat different kinds of malignancy and fast advancements in Personalized Medical Devices for the different issue.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Findings of the Report

  • Global Personalized Medical Devices Market expanding at significant CAGR over 2022 to 2028 due to increase in the awareness to providing effective communication to the consumers.
  • Based on of therapeutic area, application, end user Personalized Medical Devices segment accounted for larger market revenue share in 2021 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global Personalized Medical Devices Market market

Key

Key Features of the Report

Personalized Medical Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Becton, Dickinson and Company (USA)
  • Abbott Laboratories, Inc. (USA)
  • bioMerieux, Inc. (France)
  • Biomerica, Inc.(USA)
  • Olympus Corporation (Japan)
  • Qiagen N.V. (Geramany)
  • Siemens AG (Germany)
  • Thermo Fischer Scientific, Inc. (USA).

Description

The global Personalized Medical Devices Market size was valued at USD 494.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.3% from 2022 to 2028. Personalized Medical Devices (PM) can possibly tailor made devices with the best reaction and most noteworthy security edge to guarantee better patient care. By empowering every patient to get prior judgments, chance appraisals, and ideal medications, Personalized Medical Devices Market holds guarantee for enhancing medicinal services while additionally bringing down expenses. Medical devices companies are encountering aggressive and taken a toll weight from various sides. On one hand, rivalry emerging from developing markets requests high-volume, straightforward gadgets with bring down costs, applying weight on costs all around. Then again, organizations confront aggressive weight from new wellsprings of medicinal gadget development like added substance fabricating, which empowers unique produce of patient-particular careful instruments and implants. Some of the examples for personalized medical devices Tinnitus masker is customized by the producer to understanding tinnitus.The tinnitus treatment custom-tailors the sound signs to suit the individual patient’s listening ability necessities Pedicle screw spinal frameworks – Spinal frameworks comprising of a bar/screw/snare/connector unit are amassed by a specialist to oblige a patient’s interesting life systems/physiology utilizing MRI/CT imaging. Programming based quantitative EEG investigation intended to anticipate a person’s reaction to different psychotropic medications. The gadget gives the likelihood of reaction to different solutions to direct clinician in basic leadership. The Zenith Fenestrated AAA Endovascular Graft is demonstrated for the endovascular treatment of patients with stomach aortic or aortoiliac aneurysms having morphology reasonable for endovascular repair. The fenestrated gadget takes into account treatment of patients with shorter proximal neck lengths (i.e., length of solid aorta between the renal corridors and the aneurysm) when contrasted with the individuals who can be dealt with utilizing other endovascular joins. Every gadget is customized to the patient’s individual aortic life structures with openings in the join material set suitably to keep up blood stream to branch vessels of the aorta. The Artificial Pancreas Device System is a gadget under clinical examination that naturally screens understanding glucose levels and conveys persistent customized insulin measurements in individuals with diabetes.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX